SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MGI Pharma MOGN New patents, anti cancer
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
1826 45 0 MOGN
Emcee:  Mark Oliver Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1351MINNEAPOLIS -- MGI Pharma Inc. (MOGN) said results from a Phase 2 clinical trialJim Oravetz-11/9/2000
1350David, Basically it's a judgement call by a company whether to webcast all Biomaven-10/23/2000
1349Peter, It is now a regulation that all companies doing conference calls must prDavid Cathcart-10/23/2000
1348Thanks, David. I'll try to listen to the CC later today. This is new technolBiomaven-10/23/2000
1347Peter, Apparently there were some technical difficulties with the live web broaDavid Cathcart-10/23/2000
1346Pancreatic Cancer is Initial Phase 3 Target for MGI PHARMA's Irofulven Pivosim1-10/23/2000
1345Well I couldn't find the promised webcast on their site. Anyone else able toBiomaven-10/23/2000
1344Richard, <<Hey, will it be very, very good news or very, very, very good David Cathcart-10/20/2000
1343Hey, will it be very, very good news or very, very, very good news?seminole-10/20/2000
1342Monday morning conference call. More specifically, the conference call will bDavid Cathcart-10/20/2000
1341Conference Call; Oct 23, Monday, 9:00 et, discussion of Irofulven. There will beseminole-10/20/2000
1340I've had an opportunity to look at the French intermittent schedule dose-escBiomaven-10/20/2000
1339David Great day. When the bean counters sell, the men of science buy.seminole-10/18/2000
1338<<I thought it was Go Gamecocks Go!!!>> That too. <g> Go &#David Cathcart-10/18/2000
1337I thought it was Go Gamecocks Go!!!seminole-10/18/2000
1336Richard, <<Once a week schedule had been done in animals before.>> David Cathcart-10/18/2000
1335David <<< improved dosing schedules pioneered in France >>> seminole-10/18/2000
1334Jim, Subtract the 5.7M initial payment for MG98 and the loss was small. That iDavid Cathcart-10/18/2000
1333>> Looks like spending of clinicals is up significantly. Nature of the beascaram(o)uche-10/18/2000
1332MGI PHARMA Reports Financial Results for Third Quarter of 2000 MINNEAPOLIS, Oct.Jim Oravetz-10/18/2000
1331Weekly Dosing of Irofulven Greatly Improves Tolerance And Retains Anti-Cancer Acsim1-10/17/2000
1330David, I would imagine additional PII and PIII trials were waiting for this newm_cynova-10/16/2000
1329Good News! <i>"Dr. Jerome Alexandre at Hopital Paul Brousse observedDavid Cathcart-10/16/2000
1328biz.yahoo.com Wednesday September 27, 7:45 am Eastern Time Press Release SOURRussian Bear-9/27/2000
1327Anti-leukemic action of the novel agent MGI 114 (HMAF) and synergistic action wiJim Oravetz-9/1/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News